Clinical Trial Update: Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Clinical trial update indicates a Phase 1 multiple ascending dose study of HM12470 for Type 1 and Type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• HM12470

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type1 Diabetes Mellitus, Type2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN